Steven M. Fruchtman
2018
In 2018, Steven M. Fruchtman earned a total compensation of $970.1K as President and Chief Medical Officer at Onconova Therapeutics, a 92% increase compared to previous year.
Compensation breakdown
| Bonus | $322,304 |
|---|---|
| Option Awards | $164,361 |
| Salary | $460,840 |
| Other | $22,580 |
| Total | $970,085 |
Fruchtman received $460.8K in salary, accounting for 48% of the total pay in 2018.
Fruchtman also received $322.3K in bonus, $164.4K in option awards and $22.6K in other compensation.
Rankings
In 2018, Steven M. Fruchtman's compensation ranked 9,341st out of 14,244 executives tracked by ExecPay. In other words, Fruchtman earned more than 34.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,341 out of 14,244 | 34th |
Division Manufacturing | 3,740 out of 5,765 | 35th |
Major group Chemicals And Allied Products | 1,404 out of 2,128 | 34th |
Industry group Drugs | 1,181 out of 1,817 | 35th |
Industry Pharmaceutical Preparations | 912 out of 1,391 | 34th |
Source: SEC filing on April 29, 2019.
Fruchtman's colleagues
We found two more compensation records of executives who worked with Steven M. Fruchtman at Onconova Therapeutics in 2018.
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019